FLT PET in patienten met niet kleincellig long carcinoom behandeld met gefitinib.
Completed
- Conditions
- SCLC
- Registration Number
- NL-OMON24060
- Lead Sponsor
- VU University Medical Center (VUmc) Amsterdam
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
1. Patient age 18 years or older;
2. Histological diagnosis of NSCLC;
Exclusion Criteria
1. Pregnant or lactating patients;
2. Metal implants (e.g. pacemakers);
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The study parameters are the results of the simplified measures and the pharmacokinetic modeling of [18F]FLT PET prior to therapy and during treatment with gefitinib.
- Secondary Outcome Measures
Name Time Method Secondary, nonlinear kinetic filtering will be evaluated and perfusion measured with [15O]H2O PET.